Tech Company Financing Transactions

Reset Therapeutics Funding Round

Reset Therapeutics closed a $14.8 million funding round on 12/5/2013. Backers included private investors.

Transaction Overview

Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$14,796,231
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
260 Littlefield Ave. 200
South San Francisco, CA 94080
USA
Email Address
Overview
Reset Therapeutics is focused on harnessing the power of the body's internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications.
Profile
Reset Therapeutics LinkedIn Company Profile
Social Media
Reset Therapeutics Company Twitter Account
Company News
Reset Therapeutics News
Facebook
Reset Therapeutics on Facebook
YouTube
Reset Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ross Bersot
  Ross Bersot LinkedIn Profile  Ross Bersot Twitter Account  Ross Bersot News  Ross Bersot on Facebook
VP - Finance
Shu Kurosaki
  Shu Kurosaki LinkedIn Profile  Shu Kurosaki Twitter Account  Shu Kurosaki News  Shu Kurosaki on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/5/2013: Green Biologics venture capital transaction
Next: 12/5/2013: Glassdoor venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary